Tuesday, Cantor Fitzgerald reaffirmed its Overweight ... The firm's analyst, Olivia Brayer, provided insights into the pharmaceutical company's prospects, particularly focusing on the potential ...

Cantor Fitzgerald analyst O. Brayer now forecasts that the biopharmaceutical company will post earnings of ($2.19) per share for the year, down from their previous estimate of ($1.73). The ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on MannKind (MNKD – Research Report) yesterday and set a price target of $9.00. The company’s shares closed yesterday at $5.26.

Cantor Fitzgerald analyst Olivia Brayer initiated coverage with a Hold rating on Alnylam Pharma (ALNY – Research Report) yesterday and set a price target of $250.00. The company’s shares ...